Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

Chemotherapeutic agents without cross-resistance to prior therapies may enhance peripheral blood stem cell collection and improve patient outcomes by exacting a more potent direct anti-tumor effect prior to autologous stem cell transplant. Bendamustine has broad clinical activity in transplantable l...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052091/
https://www.ncbi.nlm.nih.gov/pubmed/27214069
http://dx.doi.org/10.1038/bmt.2016.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052091/
https://www.ncbi.nlm.nih.gov/pubmed/27214069
http://dx.doi.org/10.1038/bmt.2016.123

Ejemplares similares